Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0SZ5G
|
|||
| Former ID |
DIB013466
|
|||
| Drug Name |
ANX-042
|
|||
| Synonyms |
BNP sliced variant (heart failure), Anexon; B-type natriuretic peptide spliced variant (heart failure), Anexon
Click to Show/Hide
|
|||
| Indication | Chronic heart failure [ICD-11: BD1Z; ICD-10: I50, I50.9; ICD-9: 428] | Phase 1 | [1] | |
| Company |
Teva Pharmaceuticals USA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Natriuretic peptide receptor (NPR3) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036485) | |||
| REF 2 | Renin-Angiotensin Blockade Combined With Natriuretic Peptide System Augmentation: Novel Therapeutic Concepts to Combat Heart Failure. Circ Heart Fail. 2013 May; 6(3): 594-605. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.